Quote & Headlines
Market Currents
StockTalk
Today
5d
1m
3m
1y
5y
10y
52wk high:
52wk low:
EPS:
PE:
Div Rate:
Yield:
Market Cap:
Volume:
HEADLINES:
ALL
|
PRO
|
FOCUS
|
RELATED
|
TRANSCRIPTS
|
NEWS & PR
-
PR Newswire (May 8, 2013)
-
PR Newswire (Apr 10, 2013)
-
PR Newswire (Feb 28, 2013)
-
PR Newswire (Feb 27, 2013)
-
PR Newswire (Feb 5, 2013)
To learn more about Seeking Alpha Pro, click here.
-
6 Stocks To Watch Post Earnings On Tuesday MorningChandrasekhar Rajagopalan • Tue, Nov 13, 2012
-
5 Stocks In The News That Swung In Thursday TradingBrian Nichols • Fri, Sep 16, 2011
-
Transcept's CEO Discusses Q3 2012 Results - Earnings Call TranscriptMon, Nov 12, 2012
-
PR Newswire (May 8, 2013)
-
PR Newswire (Apr 10, 2013)
-
PR Newswire (Feb 28, 2013)
-
PR Newswire (Feb 27, 2013)
-
PR Newswire (Feb 5, 2013)
-
PR Newswire (Nov 12, 2012)
-
PR Newswire (Sep 4, 2012)
-
PR Newswire (Aug 21, 2012)
-
PR Newswire (Aug 13, 2012)
-
PR Newswire (Jul 5, 2012)
-
PR Newswire (Jun 26, 2012)
TSPT vs. ETF Alternatives
Company Description
Transcept Pharmaceuticals, Inc., or Transcept, was incorporated in Delaware in 2001 as Novacea, Inc., or Novacea. Prior to January 2008, Novacea had been principally engaged as a biopharmaceutical company focused on in-licensing, developing and commercializing novel therapies for the treatment... More




